Skip to content
healthcare.dev

childrens cetirizine hydrochloride

NDC 17856-6765, Cetirizine HCl, solution, from ATLANTIC BIOLOGICALS CORP..

Product NDC
17856-6765
Status
Listed
Labeler
ATLANTIC BIOLOGICALS CORP.
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA204226
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17856-6765 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE5 mg/5mL

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
17856-6765-11785667650172 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-6765-1) / 5 mL in 1 CUP, UNIT-DOSE
17856-6765-317856676503120 SYRINGE in 1 CASE (17856-6765-3) / 2.5 mL in 1 SYRINGE
17856-6765-91785667650990 SYRINGE in 1 CASE (17856-6765-9) / 2.5 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 17856-6765 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17856-6765 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17856-6765. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.